Search research articles
Contact Us
Filters
Showing results (51-60 of 189) with videos related to
Page
of 19
Sort By:
The Journal of Hospital Infection
|
March 1, 1981
Four-year surveillance of a special care baby unit for Pseudomonas aeruginosa
T C Haji, A Sangam, I C Willmot, et al.
Biochemical Pharmacology
|
September 1, 1986
Pyridoglutethimide [3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione], an analogue of aminoglutethimide. Metabolism and pharmacokinetics
A Seago, P E Goss, L J Griggs, et al.
Natural Product Reports
|
November 10, 1998
Inhibitors of enzymes of androgen biosynthesis: cytochrome P450(17) alpha and 5 alpha-steroid reductase
M Jarman, H J Smith, P J Nicholls, et al.
Biochemical Pharmacology
|
December 1, 1988
Inhibition of the formation of 4-hydroxyandrostenedione glucuronide by valproate
I B Parr, M G Rowlands, J Houghton, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 3, 2001
Synthesis of certain 2'-deoxyuridine derivatives containing substituted phenoxy groups attached to C-5'; evaluation as potential dUTP analogues
J H Marriott, G W Aherne, A Hardcastle, et al.
Journal of Steroid Biochemistry
|
February 1, 1986
Metabolism of 4-hydroxyandrost-4-ene-3,17-dione by rat hepatocytes
A B Foster, M Jarman, J Mann, et al.
Journal of Medicinal Chemistry
|
June 23, 1995
Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer
G A Potter, S E Barrie, M Jarman, et al.
Biochemical Pharmacology
|
January 24, 1997
Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin
M G Rowlands, R Grimshaw, M Jarman, et al.
Journal of Medicinal Chemistry
|
August 1, 1972
N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions
A B Foster, M Jarman, W C Ross, et al.
British Journal of Cancer
|
September 1, 1994
Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines
S Y Sharp, M G Rowlands, M Jarman, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 189) with videos related to
Sort By:
Page
of 19
The Journal of Hospital Infection
|
March 1, 1981
Four-year surveillance of a special care baby unit for Pseudomonas aeruginosa
T C Haji, A Sangam, I C Willmot, et al.
Biochemical Pharmacology
|
September 1, 1986
Pyridoglutethimide [3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione], an analogue of aminoglutethimide. Metabolism and pharmacokinetics
A Seago, P E Goss, L J Griggs, et al.
Natural Product Reports
|
November 10, 1998
Inhibitors of enzymes of androgen biosynthesis: cytochrome P450(17) alpha and 5 alpha-steroid reductase
M Jarman, H J Smith, P J Nicholls, et al.
Biochemical Pharmacology
|
December 1, 1988
Inhibition of the formation of 4-hydroxyandrostenedione glucuronide by valproate
I B Parr, M G Rowlands, J Houghton, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 3, 2001
Synthesis of certain 2'-deoxyuridine derivatives containing substituted phenoxy groups attached to C-5'; evaluation as potential dUTP analogues
J H Marriott, G W Aherne, A Hardcastle, et al.
Journal of Steroid Biochemistry
|
February 1, 1986
Metabolism of 4-hydroxyandrost-4-ene-3,17-dione by rat hepatocytes
A B Foster, M Jarman, J Mann, et al.
Journal of Medicinal Chemistry
|
June 23, 1995
Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer
G A Potter, S E Barrie, M Jarman, et al.
Biochemical Pharmacology
|
January 24, 1997
Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin
M G Rowlands, R Grimshaw, M Jarman, et al.
Journal of Medicinal Chemistry
|
August 1, 1972
N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions
A B Foster, M Jarman, W C Ross, et al.
British Journal of Cancer
|
September 1, 1994
Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines
S Y Sharp, M G Rowlands, M Jarman, et al.
Page
of 19